NeuroBo Pharmaceuticals (NRBO) Institutional Ownership $2.67 +0.10 (+3.89%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for NeuroBo Pharmaceuticals (NASDAQ:NRBO)CurrentInstitutional OwnershipPercentage1.37%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$3.80MNumber ofInstitutional Sellers(last 12 months)0 Get NRBO Insider Trade Alerts Want to know when executives and insiders are buying or selling NeuroBo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NRBO Institutional Buying and Selling by Quarter Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… NeuroBo Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Armistice Capital LLC696,829$3.37M0.0%N/A14.204% 8/15/2024Affinity Asset Advisors LLC89,222$432K0.0%N/A1.819% 2/14/2022Murchinson Ltd.205,256$251K0.0%N/A0.772% 11/9/2021BlackRock Inc.44,579$166K0.0%-11.3%0.200% 9/3/2021Parametric Portfolio Associates LLC16,530$55K0.0%N/A0.074% 8/16/2021State Street Corp15,878$53K0.0%-78.6%0.071% 8/13/2021Northern Trust Corp24,579$82K0.0%-68.9%0.110% 8/13/2021Vanguard Group Inc.477,918$1.59M0.0%-30.2%2.145% 8/12/2021Advisory Services Network LLC8,550$28K0.0%N/A0.038% 8/12/2021Ergoteles LLC30,800$103K0.0%N/A0.138% 8/11/2021Deutsche Bank AG31,090$104K0.0%+1,016.3%0.140% 8/4/2021 Mount Yale Investment Advisors LLC57,425$191K0.0%N/A0.258% 5/18/2021California State Teachers Retirement System9,817$43K0.0%+52.1%0.044% 5/17/2021Goldman Sachs Group Inc.10,056$44K0.0%N/A0.045% 5/13/2021Bank of New York Mellon Corp19,178$84K0.0%N/A0.087% 5/12/2021JPMorgan Chase & Co.18,449$81K0.0%+69.4%0.083% 5/7/2021BlackRock Inc.226,013$995K0.0%+2.7%1.019% 2/19/2021JPMorgan Chase & Co.10,889$57K0.0%+234.8%0.055% 2/11/2021Northern Trust Corp80,860$425K0.0%-5.4%0.411% 2/9/2021Wells Fargo & Company MN17,562$92K0.0%+1,213.5%0.089% 2/5/2021BlackRock Inc.219,989$1.15M0.0%+5.0%1.339% 11/10/2020State Street Corp41,439$233K0.0%+7.3%0.252% (Data available from 1/1/2016 forward) NRBO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRBO shares? During the previous two years, the following institutional investors and hedge funds held shares of NeuroBo Pharmaceuticals shares: Armistice Capital LLC ($3.37M), Affinity Asset Advisors LLC ($432K).Learn more on NRBO's institutional investors. What percentage of NeuroBo Pharmaceuticals stock is owned by institutional investors? 1.37% of NeuroBo Pharmaceuticals stock is owned by institutional investors. Learn more on NRBO's institutional investor holdings. Which institutional investors have been buying NeuroBo Pharmaceuticals stock? The following institutional investors have purchased NeuroBo Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($696.83K), and Affinity Asset Advisors LLC ($89.22K). How much institutional buying is happening at NeuroBo Pharmaceuticals? Institutional investors have bought a total of 786,051 shares in the last 24 months. This purchase volume represents approximately $3.80M in transactions. Related Companies Galmed Pharmaceuticals Major Shareholders Oramed Pharmaceuticals Major Shareholders InflaRx Major Shareholders Oncolytics Biotech Major Shareholders Aileron Therapeutics Major Shareholders Kazia Therapeutics Major Shareholders Purple Biotech Major Shareholders BeyondSpring Major Shareholders MediciNova Major Shareholders IO Biotech Major Shareholders This page (NASDAQ:NRBO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRBO Stock Alerts